Nov. 23 (Bloomberg) -- Roche Holding AG's Tamiflu and GlaxoSmithKline Plc's Relenza, the two most common drugs used to treat the flu, should carry warnings they may cause psychiatric side effects, U.S. regulators recommended. Nov. 23 (Bloomberg) -- Roche Holding AG's Tamiflu and GlaxoSmithKline Plc's Relenza, the two most common drugs used to treat the flu, should carry warnings they may cause psychiatric side effects, U.S. regulators recommended.
No comments:
Post a Comment